Madame Bioscience PCL (BKK:MADAME)
Thailand · Delayed Price · Currency is THB 0.9900
-0.0200 (-1.98%)
Last updated: Sep 3, 2026, 11:56 AM ICT
Madame Bioscience PCL Balance Sheet
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 127.51 | 170.26 | 80.19 | 34.34 | 252.69 | 41.26 |
Short-Term Investments | 29.18 | 23.55 | 0.43 | 0.42 | 0.65 | 11.13 |
Cash & Short-Term Investments | 156.69 | 193.81 | 80.62 | 34.76 | 253.34 | 52.39 |
Cash Growth | 261.27% | 140.41% | 131.96% | -86.28% | 383.56% | -47.52% |
Accounts Receivable | 167.63 | 130.67 | 284.08 | 293.04 | 261.71 | 310.9 |
Other Receivables | 0.42 | 8.46 | 63.98 | 42.64 | 49.17 | 35.98 |
Receivables | 168.04 | 139.13 | 348.06 | 335.68 | 310.87 | 346.87 |
Inventory | 64.04 | 47.04 | 142.02 | 237.64 | 280.56 | 361.82 |
Prepaid Expenses | 20.1 | 5.44 | 8.11 | 8.77 | 7.44 | 12.71 |
Other Current Assets | 10.79 | 14.53 | 6.55 | 17.86 | 29.81 | 66.65 |
Total Current Assets | 419.67 | 399.95 | 585.35 | 634.7 | 882.03 | 840.44 |
Property, Plant & Equipment | 349.5 | 357.09 | 675.01 | 943.3 | 1,015 | 624.97 |
Goodwill | 323.3 | 323.3 | 241.08 | 241.08 | 429.05 | 77.47 |
Other Intangible Assets | 101.59 | 107.28 | 62.49 | 67.83 | 73.34 | 5.33 |
Long-Term Deferred Tax Assets | 9.74 | - | 0.53 | 1.67 | 7.25 | 5.58 |
Other Long-Term Assets | 121.3 | 129.3 | 56.83 | 149.98 | 49.89 | 30.96 |
Total Assets | 1,325 | 1,317 | 1,621 | 2,039 | 2,457 | 1,585 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 211.19 | 134.68 | 282.28 | 242.78 | 185.02 | 209.32 |
Accrued Expenses | 0.63 | 27.95 | 36.2 | 82.52 | 47.29 | 78.1 |
Short-Term Debt | 62.77 | 46.43 | 159.79 | 161.75 | 196.61 | 138.19 |
Current Portion of Long-Term Debt | - | 42.66 | 239.46 | 363.51 | 61.86 | 31.55 |
Current Portion of Leases | 2.27 | 4.34 | 15.98 | 18.67 | 24.95 | 22.28 |
Current Income Taxes Payable | - | 1.34 | - | - | - | - |
Other Current Liabilities | 0.19 | 69.57 | 91.83 | 66.44 | 63.73 | 64.74 |
Total Current Liabilities | 277.06 | 326.97 | 825.54 | 935.67 | 579.47 | 544.18 |
Long-Term Debt | 144.38 | 141.22 | 40.9 | 102.81 | 456.24 | 97.27 |
Long-Term Leases | 8.65 | 8.97 | 158.02 | 172.92 | 182.25 | 33.88 |
Pension & Post-Retirement Benefits | 11.37 | 10.69 | 29.42 | 25.07 | 23.46 | 14.97 |
Long-Term Deferred Tax Liabilities | 32.43 | 33.19 | 21.5 | 23.02 | 24 | 5.83 |
Other Long-Term Liabilities | 1.13 | 2.16 | 2.29 | 1.79 | 0.01 | 2.61 |
Total Liabilities | 475.02 | 523.2 | 1,078 | 1,261 | 1,265 | 698.73 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 662.4 | 2,020 | 1,717 | 1,538 | 1,538 | 2,120 |
Additional Paid-In Capital | - | - | - | 59.43 | 59.43 | - |
Retained Earnings | 111.48 | -1,078 | -1,132 | -810.61 | -403.84 | -1,028 |
Comprehensive Income & Other | 32.43 | -193.17 | -84.86 | -49.19 | -49.19 | -177.68 |
Total Common Equity | 806.32 | 748.53 | 500.34 | 737.83 | 1,145 | 914.1 |
Minority Interest | 43.76 | 45.19 | 43.3 | 39.46 | 46.75 | -28.08 |
Shareholders' Equity | 850.08 | 793.72 | 543.63 | 777.28 | 1,191 | 886.03 |
Total Liabilities & Equity | 1,325 | 1,317 | 1,621 | 2,039 | 2,457 | 1,585 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 218.08 | 243.62 | 614.14 | 819.66 | 921.92 | 323.17 |
Net Cash (Debt) | -61.39 | -49.81 | -533.52 | -784.91 | -668.57 | -270.78 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.08 | -0.06 | -0.86 | -1.28 | -1.11 | -0.68 |
Filing Date Shares Outstanding | 807.81 | 4,039 | 686.8 | 615.28 | 615.28 | 423.93 |
Total Common Shares Outstanding | 807.81 | 4,039 | 686.8 | 615.28 | 615.28 | 423.93 |
Working Capital | 142.61 | 72.98 | -240.19 | -300.97 | 302.56 | 296.27 |
Book Value Per Share | 1.00 | 0.19 | 0.73 | 1.20 | 1.86 | 2.16 |
Tangible Book Value | 381.43 | 317.95 | 196.77 | 428.92 | 642.21 | 831.3 |
Tangible Book Value Per Share | 0.47 | 0.08 | 0.29 | 0.70 | 1.04 | 1.96 |
Land | - | 56.34 | 94.65 | 93.68 | 93.68 | 68.66 |
Buildings | - | 328.02 | 365.39 | 464.49 | 450.88 | 164.24 |
Machinery | - | 477.96 | 541.77 | 861.78 | 908.65 | 640.66 |
Construction In Progress | - | 1.19 | 4.08 | 7.91 | 12.97 | 150.21 |